nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.213	0.463	CbGbCtD
Pyridostigmine—CYP3A4—Progesterone—uterine cancer	0.141	0.306	CbGbCtD
Pyridostigmine—CYP3A4—Etoposide—uterine cancer	0.0631	0.137	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—uterine cancer	0.043	0.0935	CbGbCtD
Pyridostigmine—Abdominal bloating—Progesterone—uterine cancer	0.0199	0.0367	CcSEcCtD
Pyridostigmine—Abdominal bloating—Medroxyprogesterone Acetate—uterine cancer	0.018	0.0333	CcSEcCtD
Pyridostigmine—Dysmenorrhoea—Progesterone—uterine cancer	0.0104	0.0192	CcSEcCtD
Pyridostigmine—Blood pressure increased—Progesterone—uterine cancer	0.00945	0.0175	CcSEcCtD
Pyridostigmine—Dysmenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00942	0.0174	CcSEcCtD
Pyridostigmine—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00856	0.0159	CcSEcCtD
Pyridostigmine—Hypertonia—Progesterone—uterine cancer	0.00828	0.0153	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Progesterone—uterine cancer	0.00793	0.0147	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00718	0.0133	CcSEcCtD
Pyridostigmine—Cramp muscle—Progesterone—uterine cancer	0.00618	0.0114	CcSEcCtD
Pyridostigmine—Abdominal distension—Progesterone—uterine cancer	0.00597	0.0111	CcSEcCtD
Pyridostigmine—Asthma—Progesterone—uterine cancer	0.00593	0.011	CcSEcCtD
Pyridostigmine—Sweating increased—Progesterone—uterine cancer	0.00578	0.0107	CcSEcCtD
Pyridostigmine—Bronchitis—Progesterone—uterine cancer	0.0057	0.0106	CcSEcCtD
Pyridostigmine—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.0057	0.0105	CcSEcCtD
Pyridostigmine—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.0056	0.0104	CcSEcCtD
Pyridostigmine—Pollakiuria—Progesterone—uterine cancer	0.00548	0.0101	CcSEcCtD
Pyridostigmine—Chest discomfort—Etoposide—uterine cancer	0.00546	0.0101	CcSEcCtD
Pyridostigmine—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00541	0.01	CcSEcCtD
Pyridostigmine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00537	0.00995	CcSEcCtD
Pyridostigmine—Drowsiness—Progesterone—uterine cancer	0.00529	0.00979	CcSEcCtD
Pyridostigmine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00523	0.00969	CcSEcCtD
Pyridostigmine—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00517	0.00957	CcSEcCtD
Pyridostigmine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00496	0.00919	CcSEcCtD
Pyridostigmine—Lethargy—Dactinomycin—uterine cancer	0.00495	0.00916	CcSEcCtD
Pyridostigmine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00479	0.00887	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—uterine cancer	0.00461	0.00853	CcSEcCtD
Pyridostigmine—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00452	0.00837	CcSEcCtD
Pyridostigmine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00438	0.00811	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—uterine cancer	0.00426	0.0079	CcSEcCtD
Pyridostigmine—Alopecia—Progesterone—uterine cancer	0.00419	0.00776	CcSEcCtD
Pyridostigmine—Flatulence—Progesterone—uterine cancer	0.00407	0.00754	CcSEcCtD
Pyridostigmine—Muscle spasms—Progesterone—uterine cancer	0.00397	0.00735	CcSEcCtD
Pyridostigmine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.0038	0.00704	CcSEcCtD
Pyridostigmine—Vertigo—Progesterone—uterine cancer	0.00371	0.00687	CcSEcCtD
Pyridostigmine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00369	0.00683	CcSEcCtD
Pyridostigmine—Loss of consciousness—Progesterone—uterine cancer	0.00363	0.00672	CcSEcCtD
Pyridostigmine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.0036	0.00666	CcSEcCtD
Pyridostigmine—Convulsion—Progesterone—uterine cancer	0.00358	0.00663	CcSEcCtD
Pyridostigmine—Myalgia—Progesterone—uterine cancer	0.00352	0.00651	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—uterine cancer	0.00351	0.0065	CcSEcCtD
Pyridostigmine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.00637	CcSEcCtD
Pyridostigmine—Confusional state—Progesterone—uterine cancer	0.0034	0.00629	CcSEcCtD
Pyridostigmine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00336	0.00623	CcSEcCtD
Pyridostigmine—Cardiac arrest—Etoposide—uterine cancer	0.00334	0.00618	CcSEcCtD
Pyridostigmine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.00609	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Progesterone—uterine cancer	0.00326	0.00603	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—uterine cancer	0.00325	0.00601	CcSEcCtD
Pyridostigmine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00324	0.00601	CcSEcCtD
Pyridostigmine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.0059	CcSEcCtD
Pyridostigmine—Cramp muscle—Etoposide—uterine cancer	0.00316	0.00585	CcSEcCtD
Pyridostigmine—Hypotension—Progesterone—uterine cancer	0.00315	0.00583	CcSEcCtD
Pyridostigmine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.0057	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00307	0.00569	CcSEcCtD
Pyridostigmine—Paraesthesia—Progesterone—uterine cancer	0.00303	0.00561	CcSEcCtD
Pyridostigmine—Somnolence—Progesterone—uterine cancer	0.003	0.00555	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—uterine cancer	0.00296	0.00549	CcSEcCtD
Pyridostigmine—Sweating increased—Etoposide—uterine cancer	0.00295	0.00547	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00295	0.00547	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—uterine cancer	0.00294	0.00544	CcSEcCtD
Pyridostigmine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.00529	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00278	0.00515	CcSEcCtD
Pyridostigmine—Feeling abnormal—Progesterone—uterine cancer	0.00278	0.00514	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Progesterone—uterine cancer	0.00276	0.0051	CcSEcCtD
Pyridostigmine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00508	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—uterine cancer	0.00274	0.00508	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—uterine cancer	0.00272	0.00504	CcSEcCtD
Pyridostigmine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00503	CcSEcCtD
Pyridostigmine—Urticaria—Progesterone—uterine cancer	0.00268	0.00496	CcSEcCtD
Pyridostigmine—Abdominal pain—Progesterone—uterine cancer	0.00267	0.00493	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—uterine cancer	0.00263	0.00487	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—uterine cancer	0.00254	0.0047	CcSEcCtD
Pyridostigmine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00466	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00463	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—uterine cancer	0.00249	0.0046	CcSEcCtD
Pyridostigmine—Hypersensitivity—Progesterone—uterine cancer	0.00248	0.0046	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00244	0.00451	CcSEcCtD
Pyridostigmine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.00449	CcSEcCtD
Pyridostigmine—Asthenia—Progesterone—uterine cancer	0.00242	0.00448	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Etoposide—uterine cancer	0.00242	0.00447	CcSEcCtD
Pyridostigmine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00242	0.00447	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—uterine cancer	0.00241	0.00447	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—uterine cancer	0.00238	0.0044	CcSEcCtD
Pyridostigmine—Diarrhoea—Progesterone—uterine cancer	0.00231	0.00427	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—uterine cancer	0.00227	0.00421	CcSEcCtD
Pyridostigmine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00417	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—uterine cancer	0.00223	0.00413	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—uterine cancer	0.0022	0.00407	CcSEcCtD
Pyridostigmine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00406	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—uterine cancer	0.00218	0.00403	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00217	0.00402	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—uterine cancer	0.00215	0.00397	CcSEcCtD
Pyridostigmine—Vomiting—Progesterone—uterine cancer	0.00214	0.00397	CcSEcCtD
Pyridostigmine—Rash—Progesterone—uterine cancer	0.00213	0.00394	CcSEcCtD
Pyridostigmine—Dermatitis—Progesterone—uterine cancer	0.00212	0.00393	CcSEcCtD
Pyridostigmine—Headache—Progesterone—uterine cancer	0.00211	0.00391	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—uterine cancer	0.0021	0.00389	CcSEcCtD
Pyridostigmine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00387	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—uterine cancer	0.00203	0.00376	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—uterine cancer	0.00202	0.00373	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—uterine cancer	0.00201	0.00372	CcSEcCtD
Pyridostigmine—Nausea—Progesterone—uterine cancer	0.002	0.00371	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—uterine cancer	0.00196	0.00364	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00195	0.00361	CcSEcCtD
Pyridostigmine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.0036	CcSEcCtD
Pyridostigmine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00357	CcSEcCtD
Pyridostigmine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.00356	CcSEcCtD
Pyridostigmine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00354	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—uterine cancer	0.0019	0.00352	CcSEcCtD
Pyridostigmine—Abdominal pain—Dactinomycin—uterine cancer	0.00188	0.00349	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—uterine cancer	0.00187	0.00346	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—uterine cancer	0.00186	0.00344	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—uterine cancer	0.00186	0.00344	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—uterine cancer	0.00183	0.00339	CcSEcCtD
Pyridostigmine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00336	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—uterine cancer	0.0018	0.00334	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—uterine cancer	0.00176	0.00325	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—uterine cancer	0.00174	0.00322	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—uterine cancer	0.00173	0.0032	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—uterine cancer	0.00171	0.00317	CcSEcCtD
Pyridostigmine—Asthenia—Dactinomycin—uterine cancer	0.00171	0.00317	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—uterine cancer	0.0017	0.00315	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—uterine cancer	0.00167	0.00309	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—uterine cancer	0.00167	0.00309	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—uterine cancer	0.00164	0.00303	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—uterine cancer	0.00163	0.00302	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—uterine cancer	0.00161	0.00298	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—uterine cancer	0.00158	0.00293	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—uterine cancer	0.00157	0.00291	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—uterine cancer	0.00157	0.00291	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—uterine cancer	0.00155	0.00287	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—uterine cancer	0.00153	0.00284	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—uterine cancer	0.00152	0.00281	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—uterine cancer	0.00152	0.00281	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—uterine cancer	0.00151	0.0028	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—uterine cancer	0.0015	0.00278	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—uterine cancer	0.00145	0.00269	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—uterine cancer	0.00143	0.00265	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—uterine cancer	0.00142	0.00263	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—uterine cancer	0.00142	0.00262	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—uterine cancer	0.00141	0.00261	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—uterine cancer	0.0014	0.0026	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—uterine cancer	0.00139	0.00256	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—uterine cancer	0.00137	0.00254	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—uterine cancer	0.00136	0.00252	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—uterine cancer	0.00135	0.00251	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—uterine cancer	0.00132	0.00245	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—uterine cancer	0.00128	0.00237	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—uterine cancer	0.00127	0.00235	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—uterine cancer	0.00125	0.00232	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—uterine cancer	0.00124	0.00229	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—uterine cancer	0.0012	0.00223	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—uterine cancer	0.00118	0.00218	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—uterine cancer	0.00117	0.00216	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—uterine cancer	0.00114	0.00211	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—uterine cancer	0.00111	0.00206	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—uterine cancer	0.0011	0.00203	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—uterine cancer	0.00109	0.00202	CcSEcCtD
Pyridostigmine—Rash—Etoposide—uterine cancer	0.00109	0.00201	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—uterine cancer	0.00109	0.00201	CcSEcCtD
Pyridostigmine—Headache—Etoposide—uterine cancer	0.00108	0.002	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—uterine cancer	0.00108	0.002	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—uterine cancer	0.00106	0.00197	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—uterine cancer	0.00105	0.00195	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—uterine cancer	0.00104	0.00193	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—uterine cancer	0.00103	0.0019	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—uterine cancer	0.00102	0.0019	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—uterine cancer	0.00101	0.00187	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—uterine cancer	0.00101	0.00186	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—uterine cancer	0.000985	0.00182	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—uterine cancer	0.000975	0.0018	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—uterine cancer	0.000963	0.00178	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—uterine cancer	0.00095	0.00176	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—uterine cancer	0.000935	0.00173	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—uterine cancer	0.000933	0.00173	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—uterine cancer	0.000903	0.00167	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—uterine cancer	0.000902	0.00167	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000881	0.00163	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—uterine cancer	0.000868	0.00161	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000865	0.0016	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—uterine cancer	0.00086	0.00159	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—uterine cancer	0.000836	0.00155	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000815	0.00151	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—uterine cancer	0.000803	0.00149	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—uterine cancer	0.000797	0.00148	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—uterine cancer	0.000795	0.00147	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000791	0.00146	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—uterine cancer	0.000768	0.00142	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—uterine cancer	0.000764	0.00142	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—uterine cancer	0.000737	0.00136	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000732	0.00135	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—uterine cancer	0.000712	0.00132	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—uterine cancer	0.000711	0.00132	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—uterine cancer	0.000707	0.00131	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—uterine cancer	0.000694	0.00128	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—uterine cancer	0.000662	0.00122	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—uterine cancer	0.000659	0.00122	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—uterine cancer	0.000642	0.00119	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—uterine cancer	0.000615	0.00114	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—uterine cancer	0.000612	0.00113	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—uterine cancer	0.00061	0.00113	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—uterine cancer	0.000609	0.00113	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—uterine cancer	0.000606	0.00112	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—uterine cancer	0.000574	0.00106	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—uterine cancer	0.000569	0.00105	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—uterine cancer	0.000564	0.00104	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—uterine cancer	0.000564	0.00104	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—uterine cancer	0.00056	0.00104	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—uterine cancer	0.000531	0.000984	CcSEcCtD
